NeuroOne Medical Technologies Corporation — Operating Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/4f86b4ec-1123-4778-8a36-7d555bef1f18/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-4.2M | 2024-10-01 – 2025-09-30 | evidence 0001213900-25-122390 |
| FY 2024 | $-11.9M | 2023-10-01 – 2024-09-30 | evidence 0001213900-24-109524 |
| FY 2023 | $-12.0M | 2022-10-01 – 2023-09-30 | evidence 0001213900-23-096120 |
| FY 2022 | $-10.0M | 2021-10-01 – 2022-09-30 | evidence 0001213900-22-081897 |
| FY 2021 | $-10.2M | 2020-10-01 – 2021-09-30 | evidence 0001213900-21-065463 |
| FY 2020 | $-4.9M | 2019-10-01 – 2020-09-30 | evidence 0001213900-20-041661 |
| FY 2019 | $-5.8M | 2018-10-01 – 2019-09-30 | evidence 0001213900-19-026720 |
| FY 2017 | $-3.1M | 2017-01-01 – 2017-12-31 | evidence 0001213900-18-017239 |
| FY 2016 | $-32.6k | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-020684 |
| FY 2015 | $-30.9k | 2015-01-01 – 2015-12-31 | evidence 0001144204-17-020684 |
| FY 2014 | $-35.9k | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-023047 |
| FY 2013 | $-79.0k | 2009-08-20 – 2014-03-31 | evidence 0001144204-14-032425 |
| FY 2012 | $-13.7k | 2012-01-01 – 2012-12-31 | evidence 0001144204-14-024610 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
NeuroOne Medical Technologies Corporation — all facts · Revenue · Net Income